Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2009-05-25 Regulatory Filings
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Regulatory Filings 2009
Regulatory Filings
2009-05-25 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (245 characters) and appears to be a formal announcement from a company listed on the OMX Nordic Exchange Copenhagen. The title is "Fondsbørsmeddelelse" (Stock Exchange Announcement) and the content explicitly states the calculated 'Indre værdi' (Net Asset Value or NAV) for a specific date (May 25, 2009) as 39.10. This directly corresponds to the definition of a Net Asset Value update, which is classified as NAV.
2009-05-25 English
Regulatory Filings 2009
Regulatory Filings
2009-05-20 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (245 characters) and appears to be a formal announcement from a company via the OMX Nordic Exchange Copenhagen. The content explicitly states the 'Indre værdi' (Net Asset Value) calculated for a specific date (May 20, 2009) as 39.17. This directly corresponds to the definition of a Net Asset Value update, which is classified as NAV.
2009-05-20 English
Regulatory Filings 2009
Regulatory Filings
2009-05-19 Danish
Net Asset Value 2009
Net Asset Value Classification · 99% confidence The document is extremely short (245 characters) and appears to be a formal announcement from a Danish exchange (OMX Nordic Exchange Copenhagen). The content explicitly states the 'Indre værdi' (Net Asset Value or NAV) calculated for a specific date (May 19, 2009) as 39.18. This directly corresponds to the definition of a Net Asset Value update, which is classified as NAV.
2009-05-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.